通心络联合阿托伐他汀、阿司匹林对新西兰兔动脉粥样硬化早期颈动脉外膜滋养血管新生相关炎症机制的影响

《通心络联合阿托伐他汀、阿司匹林对新西兰兔动脉粥样硬化早期颈动脉外膜滋养血管新生相关炎症机制的影响》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、授予单位代码10089学号或申请号20122566HebeiMedicalUniversity硕士学位论文科学学位通心络联合阿托伐他汀、阿司匹林对新西兰兔动脉粥样硬化早期颈动脉外膜滋养血管新生相关炎症机制的影响研究生：郎艳松导师：吴以岭院士专业：中西医结合临床二级学院：以岭医药集团2015年3月河北医科大学学位论文使用授权及知识产权归属承诺本学位论文在导师（或指导小组）的指导下，由本人独立完成。本学位论文研究所获得的研宄成果，其知识产权归河北医科大学所有。河北医科大学有权对本学位论文进行交流、公开和使用。凡

2、发表与学位论文主要内容相关的论文，第一署名为单位河北医科大学，试验材料、原始数据、申报的专利等知识产权均归河北医科大学所有。否则，承担相应法律责任。研宄生签名名j二级学院领导盖章河北医科大学研究生学位论文独创性声明本论文是在导师指导下进行的研宄工作及取得的研宄成果，除了文中特别加以标注和致谢等内容外，文中不包含其他人已经发表或撰写的研宄成果，指导教师对此进行了审定。本论文由本人独立撰写，文责自负。研究生签名：导师签；：w丨年>月对日目录中文摘要································

3、················································1英文摘要················································································5英文缩写··············································································11研究论文通心络联合阿托伐他汀、阿司匹林对新西兰兔动脉粥样硬化早期颈动脉外膜滋

4、养血管新生相关炎症机制的影响引言··············································································12第一部分“金三角”方案对新西兰兔动脉粥样硬化早期模型的干预作用前言··············································································15材料与方法··········································

5、···························15结果··············································································20附图··············································································22附表·····························································

6、·················24讨论··············································································25小结··············································································27参考文献·····································································

7、···28第二部分“金三角”方案对新西兰兔动脉粥样硬化早期颈动脉外膜滋养血管新生的干预作用前言··············································································32材料与方法·····································································32结果···················································

8、···························38附图··············································································39附表··············································································42讨论·············